3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
54
Squamous Cell Carcinoma of Head and Neck
4
Sarcoma
4
Neoplasm Metastasis
4
Sarcoma, Ewing
3
Neoplasms
3
Medulloblastoma
3
Lymphoma, Non-Hodgkin
3
Glioma
3
Carcinoma, Non-Small-Cell Lung
3
Astrocytoma
3
Wilms Tumor
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Recurrence
2
Osteosarcoma
2
Oligodendroglioma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Lymphoma
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioblastoma
2
Ependymoma
2
Colonic Neoplasms
2
Xanthogranuloma, Juvenile
1
Triple Negative Breast Neoplasms
1
Testicular Neoplasms
1
Teratoma
1
Recurrent Squamous Cell Lung Carcinoma
1
Interventions
Tamoxifen
9
Letrozole
5
Anastrozole
5
Radiotherapy
3
Radiation
3
Neoadjuvant Therapy
3
afimoxifene
2
Trastuzumab
2
Surgical Procedures, Operative
2
Simvastatin
2
Sentinel Lymph Node Biopsy
2
Radiation Dose Hypofractionation
2
Mastectomy, Segmental
2
Lapatinib
2
Gene Expression Profiling
2
trastuzumab biosimilar HLX02
1
telapristone acetate
1
sargramostim
1
polyphenon E
1
pasireotide
1
palbociclib
1
oxybutynin
1
liposomal doxorubicin
1
exemestane
1
Zoledronic Acid
1
UAB 30
1
Tea
1
Sugars
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Intraductal, Noninfiltrating
×
palbociclib
×
Clear all
NCT03535506
2025-09-26
WI223281
Georgetown University
Phase 2
Terminated
17 enrolled
9 charts